By reviewing the data and tweets, can we predict if the closing price of $gild will go upwards or downwards at 2017-05-01? Please indicate either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-04-17,0.2,0.7,-0.1,0.3,0.3,-0.5,-0.2,0.2,0.6,1.0,1.3
2017-04-18,0.8,1.2,-0.5,-1.0,-1.0,0.4,0.6,1.1,1.4,1.8,2.1
2017-04-19,-0.1,0.2,-0.6,0.3,0.3,0.1,0.1,0.6,0.9,1.4,1.6
2017-04-20,-0.2,0.3,-0.5,0.3,0.3,-0.1,-0.2,0.2,0.5,1.0,1.1
2017-04-21,0.9,1.1,-0.3,-0.9,-0.9,0.6,0.6,0.9,1.2,1.7,1.9
2017-04-24,0.4,0.4,-0.8,0.5,0.5,-0.1,0.1,0.3,0.7,1.0,1.4
2017-04-25,-0.8,0.6,-0.8,1.3,1.3,-1.0,-1.1,-1.0,-0.7,-0.4,0.0
2017-04-26,-1.2,0.6,-1.4,1.6,1.6,-2.1,-2.4,-2.5,-2.2,-2.0,-1.6
2017-04-27,-0.6,0.3,-0.8,0.5,0.5,-2.0,-2.6,-2.8,-2.6,-2.4,-2.1
2017-04-28,0.4,0.6,-0.5,-0.0,-0.0,-1.2,-2.2,-2.6,-2.5,-2.3,-2.0

2017-04-17: $gild possible short. - s: $66.61 / sl: $67.14 |$gild is in three outside up winning 66.67% in the past. |AT_USER thx jason!  $abt also announced another buyout today. $gild is a fav of mine just wond
2017-04-18: AT_USER AT_USER $gild tomorrow what?|rt AT_USER $gild says earnings will be may 2nd. live shot of the analyst/investor community if there's been no progress on the deal fr¡­|rt AT_USER $gild says earn
2017-04-19: AT_USER AT_USER yup, my thoughts exactly. money will flow from consumer discretionary to staples and healthc¡­ |curious if anyone has any thoughts on $gild|rt AT_USER incyte: buy on the drop?  $abbv $
2017-04-20: #gileadsciences gilead to present clinical and preclinical data on nonalcoholic steatohepat... read more:  $gild|rt AT_USER $gs : from 2011 to 2017 biotech cumulative market caps have increased by $50
2017-04-21: rt AT_USER gilead offers a glimpse at hard data to back up its $600m investment in nimbus¡¯ #nash drug $gild  by AT_USER|rt AT_USER $gild ceo doesn't m/a before earnings, probably will be looking for 
2017-04-22: you could splurge with your tax refund, but investing is a better idea #stocks $celg, $gild, $mpw |rt AT_USER new report halves the number of people infected with hepatitis c worldwide | science $gild
2017-04-23: rt AT_USER  millionaire road map trading top students win a porsche for a yr! $lnkd $cvx $gild $stx $p| millionaire road map trading top students win a porsche for a yr! $lnkd $cvx $gild $stx $p|shoul
2017-04-24: rt AT_USER #tradetalks AT_USER trading call spreads AT_USER interviews me at the marketsite  ¡­ $gil¡­|rt AT_USER #tradetalks AT_USER trading call spreads AT_USER interviews me at the marketsite  ¡­ $
2017-04-25: $gild $mrk |AT_USER sifted through the litter down here at the lows $gild $tgt.... thinking the worst is over for these ...|$gild is in parabolic sar breakout winning 60.29% in the past. |according to
2017-04-26: biogen's 1q17 results: eps falls in spite of solid revenue growth  $biib $amgn $gild $celg|rt AT_USER extreme leverage? extreme valuations? big-time short sellers must be thinking about it  $gild $spy
2017-04-27: now imo tomorrow is ripe for $gild to say something extraordinary ., great chance for biotech to break our|analysts set gilead sciences, inc. $gild target price at $80.82 |analysts set gilead sciences
2017-04-28: $googl #seo #searchengineoptimization #bots #like #retweeting from  $gild $snap $f #fridayfeeling|$googl #seo #searchengineoptimization #bots #like #retweeting from  $gild $snap $f #fridayfeeling|$goo
2017-04-29: 3 things in biotech you should learn today: april 29, 2017  $bayzf $gild $pfe|3 things in biotech you should learn today: april 29, 2017 $bayzf $gild $pfe  #investing¡­ |3 things in biotech you should
2017-04-30: $gild earnings how bad:|AT_USER but what about $gild? hahaha|gilead: will q1 earnings even matter?   $gild $jnj $gsk  #shockingthestreet |earnings growth &amp; revenue growth that will be to release o
Answer:
By reviewing the data and tweets, can we predict if the closing price of $gild will go upwards or downwards at 2017-05-01? Please indicate either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-04-17,0.2,0.7,-0.1,0.3,0.3,-0.5,-0.2,0.2,0.6,1.0,1.3
2017-04-18,0.8,1.2,-0.5,-1.0,-1.0,0.4,0.6,1.1,1.4,1.8,2.1
2017-04-19,-0.1,0.2,-0.6,0.3,0.3,0.1,0.1,0.6,0.9,1.4,1.6
2017-04-20,-0.2,0.3,-0.5,0.3,0.3,-0.1,-0.2,0.2,0.5,1.0,1.1
2017-04-21,0.9,1.1,-0.3,-0.9,-0.9,0.6,0.6,0.9,1.2,1.7,1.9
2017-04-24,0.4,0.4,-0.8,0.5,0.5,-0.1,0.1,0.3,0.7,1.0,1.4
2017-04-25,-0.8,0.6,-0.8,1.3,1.3,-1.0,-1.1,-1.0,-0.7,-0.4,0.0
2017-04-26,-1.2,0.6,-1.4,1.6,1.6,-2.1,-2.4,-2.5,-2.2,-2.0,-1.6
2017-04-27,-0.6,0.3,-0.8,0.5,0.5,-2.0,-2.6,-2.8,-2.6,-2.4,-2.1
2017-04-28,0.4,0.6,-0.5,-0.0,-0.0,-1.2,-2.2,-2.6,-2.5,-2.3,-2.0

2017-04-17: $gild possible short. - s: $66.61 / sl: $67.14 |$gild is in three outside up winning 66.67% in the past. |AT_USER thx jason!  $abt also announced another buyout today. $gild is a fav of mine just wond
2017-04-18: AT_USER AT_USER $gild tomorrow what?|rt AT_USER $gild says earnings will be may 2nd. live shot of the analyst/investor community if there's been no progress on the deal fr¡­|rt AT_USER $gild says earn
2017-04-19: AT_USER AT_USER yup, my thoughts exactly. money will flow from consumer discretionary to staples and healthc¡­ |curious if anyone has any thoughts on $gild|rt AT_USER incyte: buy on the drop?  $abbv $
2017-04-20: #gileadsciences gilead to present clinical and preclinical data on nonalcoholic steatohepat... read more:  $gild|rt AT_USER $gs : from 2011 to 2017 biotech cumulative market caps have increased by $50
2017-04-21: rt AT_USER gilead offers a glimpse at hard data to back up its $600m investment in nimbus¡¯ #nash drug $gild  by AT_USER|rt AT_USER $gild ceo doesn't m/a before earnings, probably will be looking for 
2017-04-22: you could splurge with your tax refund, but investing is a better idea #stocks $celg, $gild, $mpw |rt AT_USER new report halves the number of people infected with hepatitis c worldwide | science $gild
2017-04-23: rt AT_USER  millionaire road map trading top students win a porsche for a yr! $lnkd $cvx $gild $stx $p| millionaire road map trading top students win a porsche for a yr! $lnkd $cvx $gild $stx $p|shoul
2017-04-24: rt AT_USER #tradetalks AT_USER trading call spreads AT_USER interviews me at the marketsite  ¡­ $gil¡­|rt AT_USER #tradetalks AT_USER trading call spreads AT_USER interviews me at the marketsite  ¡­ $
2017-04-25: $gild $mrk |AT_USER sifted through the litter down here at the lows $gild $tgt.... thinking the worst is over for these ...|$gild is in parabolic sar breakout winning 60.29% in the past. |according to
2017-04-26: biogen's 1q17 results: eps falls in spite of solid revenue growth  $biib $amgn $gild $celg|rt AT_USER extreme leverage? extreme valuations? big-time short sellers must be thinking about it  $gild $spy
2017-04-27: now imo tomorrow is ripe for $gild to say something extraordinary ., great chance for biotech to break our|analysts set gilead sciences, inc. $gild target price at $80.82 |analysts set gilead sciences
2017-04-28: $googl #seo #searchengineoptimization #bots #like #retweeting from  $gild $snap $f #fridayfeeling|$googl #seo #searchengineoptimization #bots #like #retweeting from  $gild $snap $f #fridayfeeling|$goo
2017-04-29: 3 things in biotech you should learn today: april 29, 2017  $bayzf $gild $pfe|3 things in biotech you should learn today: april 29, 2017 $bayzf $gild $pfe  #investing¡­ |3 things in biotech you should
2017-04-30: $gild earnings how bad:|AT_USER but what about $gild? hahaha|gilead: will q1 earnings even matter?   $gild $jnj $gsk  #shockingthestreet |earnings growth &amp; revenue growth that will be to release o
Answer:+Fall